[go: up one dir, main page]

NO20022420L - Forbedret transdermalt svangerskapsforebyggende avleveringssystem og fremgangsmåte - Google Patents

Forbedret transdermalt svangerskapsforebyggende avleveringssystem og fremgangsmåte

Info

Publication number
NO20022420L
NO20022420L NO20022420A NO20022420A NO20022420L NO 20022420 L NO20022420 L NO 20022420L NO 20022420 A NO20022420 A NO 20022420A NO 20022420 A NO20022420 A NO 20022420A NO 20022420 L NO20022420 L NO 20022420L
Authority
NO
Norway
Prior art keywords
delivery system
contraceptive delivery
improved transdermal
transdermal contraceptive
improved
Prior art date
Application number
NO20022420A
Other languages
English (en)
Other versions
NO20022420D0 (no
NO331218B1 (no
Inventor
Te-Yen Chien
Original Assignee
Agile Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agile Therapeutics Inc filed Critical Agile Therapeutics Inc
Publication of NO20022420D0 publication Critical patent/NO20022420D0/no
Publication of NO20022420L publication Critical patent/NO20022420L/no
Publication of NO331218B1 publication Critical patent/NO331218B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20022420A 1999-11-24 2002-05-22 Transdermalt befruktningshindrende avleveringssystem NO331218B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16753599P 1999-11-24 1999-11-24
PCT/US2000/032043 WO2001037770A1 (en) 1999-11-24 2000-11-22 Improved transdermal contraceptive delivery system and process

Publications (3)

Publication Number Publication Date
NO20022420D0 NO20022420D0 (no) 2002-05-22
NO20022420L true NO20022420L (no) 2002-07-18
NO331218B1 NO331218B1 (no) 2011-11-07

Family

ID=22607771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022420A NO331218B1 (no) 1999-11-24 2002-05-22 Transdermalt befruktningshindrende avleveringssystem

Country Status (21)

Country Link
EP (1) EP1242012B1 (no)
JP (2) JP4841781B2 (no)
KR (1) KR100758757B1 (no)
CN (1) CN1399533A (no)
AR (1) AR030037A1 (no)
AT (1) ATE453374T1 (no)
AU (2) AU784196B2 (no)
BR (1) BR0015802B1 (no)
CA (1) CA2391430C (no)
CY (1) CY1110615T1 (no)
DE (1) DE60043621D1 (no)
DK (1) DK1242012T3 (no)
ES (1) ES2338860T3 (no)
IL (1) IL149655A0 (no)
MX (1) MXPA02005224A (no)
NO (1) NO331218B1 (no)
NZ (1) NZ518723A (no)
PT (1) PT1242012E (no)
TW (1) TWI253350B (no)
WO (1) WO2001037770A1 (no)
ZA (1) ZA200203525B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384650B2 (en) 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US7045145B1 (en) 1999-11-24 2006-05-16 Agile Therapeutics, Inc. Transdermal contraceptive delivery system and process
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
PT1594483E (pt) 2003-02-21 2006-12-29 Schering Ag Penso transdérmico estável aos uv
JP2006525358A (ja) * 2003-05-02 2006-11-09 ドゥラメド ファーマシューティカルズ, インコーポレイテッド 長期周期避妊養生法を利用するホルモン治療の方法
CN100457064C (zh) * 2003-10-28 2009-02-04 诺芬药品公司 透皮递药装置
UA89766C2 (en) 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
CN1313084C (zh) * 2004-11-05 2007-05-02 郑会义 一种透皮避孕药传送体系及制备方法
CN1318032C (zh) * 2005-01-24 2007-05-30 浙江大学 炔雌醇透皮吸收贴片
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2008088593A2 (en) * 2006-09-27 2008-07-24 Surmodics, Inc. Additives and methods for enhancing active agent elution kinetics
GB0809905D0 (en) * 2008-06-02 2008-07-09 Secr Defence A Transdermal drug delivery device
CN102665683A (zh) 2009-10-12 2012-09-12 丽卡实验有限公司 紧急避孕药
CA2798034A1 (en) * 2010-03-28 2011-10-13 Evestra, Inc. Intravaginal drug delivery device
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
HK1200317A1 (en) * 2011-11-04 2015-08-07 Agile Therapeutics, Inc. Dermal delivery compositions and methods
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
WO2014100599A1 (en) * 2012-12-21 2014-06-26 Teikoku Pharma Usa, Inc. Compositions and methods for transdermal delivery of hormones and other medicinal agents
AR094289A1 (es) 2012-12-28 2015-07-22 Noven Pharma Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
HK1251938A1 (zh) * 2015-05-18 2019-05-03 敏捷治疗公司 避孕组合物及提高效能和调节副作用的方法
KR102652671B1 (ko) 2023-12-26 2024-03-29 주식회사 스몰랩 피임 마이크로니들용 미립구 조성물 및 이를 포함한 피임 마이크로니들

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632740A (en) * 1968-06-13 1972-01-04 Johnson & Johnson Topical device for the therapeutic management of dermatological lesions with steroids
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
NZ275615A (en) * 1993-09-29 1996-11-26 Alza Corp Oxybutynin composition containing monoglyceride and lactate ester as permeability enhancers; device for transdermal administration of oxybutynin
WO1996015793A1 (en) * 1994-11-17 1996-05-30 Toray Industries, Inc. Percutaneously absorbable preparation
PT836506E (pt) * 1995-06-07 2003-04-30 Ortho Mcneil Pharm Inc Penso transdermico para administracao de 17-desacetil norgestimato so ou em combinacao com um estrogenio
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process

Also Published As

Publication number Publication date
IL149655A0 (en) 2002-11-10
CY1110615T1 (el) 2015-04-29
CN1399533A (zh) 2003-02-26
NO20022420D0 (no) 2002-05-22
ES2338860T3 (es) 2010-05-13
AU2006201918A1 (en) 2006-06-01
NZ518723A (en) 2004-04-30
AU2006201918B2 (en) 2009-07-30
EP1242012B1 (en) 2009-12-30
MXPA02005224A (es) 2003-09-25
DE60043621D1 (de) 2010-02-11
CA2391430A1 (en) 2001-05-31
PT1242012E (pt) 2010-03-31
JP2003533434A (ja) 2003-11-11
JP4841781B2 (ja) 2011-12-21
DK1242012T3 (da) 2010-04-26
ATE453374T1 (de) 2010-01-15
EP1242012A1 (en) 2002-09-25
BR0015802B1 (pt) 2014-04-29
KR20020072280A (ko) 2002-09-14
KR100758757B1 (ko) 2007-09-14
AU784196B2 (en) 2006-02-23
TWI253350B (en) 2006-04-21
AR030037A1 (es) 2003-08-13
JP2011231125A (ja) 2011-11-17
ZA200203525B (en) 2003-07-18
NO331218B1 (no) 2011-11-07
CA2391430C (en) 2009-10-06
EP1242012A4 (en) 2006-05-31
BR0015802A (pt) 2003-06-24
AU1788301A (en) 2001-06-04
WO2001037770A1 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
DK1242012T3 (da) Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde
FI20011887L (fi) Kantapäälaite ja -menetelmä
EP1181073A4 (en) SYSTEM AND METHOD FOR VESTICULAR STIMULATION
DE60044764D1 (de) Durchgangs -Vorrichtung und -Verfahren
DE60045044D1 (de) Angesichtsphotographiervorrichtung und -verfahren
NO20016277D0 (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer
GB9918348D0 (en) Location finding system and method
DE60045669D1 (de) Kommunikationssystem und Verfahren sowie Kommunikationsvorrichtung und Verfahren
ATE311741T1 (de) Ernteverfahren und erntevorrichtung
DE60014208D1 (de) Druckvorrichtung und -verfahren
NO993680L (no) Forankringsanordning og fremgangsmåte
AU2938100A (en) Transdermal drug delivery system and method
NO20000188D0 (no) Fremgangsmåte og anordning for sidebroenntilknytning
NO20002584L (no) Brønnreferanseapparat og fremgangsmÕte
DE60016291D1 (de) Verbindungssystem und -verfahren
FI20000715A0 (fi) Ryhmätyömenetelmä ja -järjestelmä
DK1164996T3 (da) Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner
IL133208A0 (en) Affiliate dissemination method and system
DE60001791D1 (de) Bilderzeugungsgerät und -Verfahren
DE50012218D1 (de) Frankierverfahren und -vorrichtung
FI19991928L (fi) Punnitusmenetelmä ja -järjestely
DE60041297D1 (de) Empfangsgerät und- Verfahren
IT1295010B1 (it) Sistema e metodo di telecomunicazione utilizzante ponti radio
FI19992817L (fi) Rakennustekninen menetelmä ja laite
NO20022482L (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees